首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATIC HYPERPLASIA, USE THEREOF AND METHOD FOR TREATING PROSTATIC HYPERPLASIA

PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATIC HYPERPLASIA, USE THEREOF AND METHOD FOR TREATING PROSTATIC HYPERPLASIA

机译：治疗前列腺增生症的药物组合物，其用途和治疗前列腺增生症的方法

页面导航

摘要
著录项
相似文献

摘要

The invention relates to medicine and concerns a pharmaceutical composition comprising Ala-Asp-Glu, Lys-Asp-Glu and Asp-Glu-Gly peptides, which is active in respect to benign prostatic hyperplasia, use thereof for treating benign prostatic hyperplasia and a method for treating benign prostatic hyperplasia. The composition has a strong effects that considerably higher than that of α₁-adrenoblockers and 5α-reductase. This effect allows to use the pharmaceutical composition comprising Ala-Asp-Glu, Lys-Asp-Glu and Asp-Glu-Gly peptides for treating benign prostatic hyperplasia.

机译：本发明涉及药物，涉及包含对前列腺增生具有活性的Ala-Asp-Glu，Lys-Asp-Glu和Asp-Glu-Gly肽的药物组合物，其用于以下用途治疗前列腺增生和治疗前列腺增生的方法。该组合物具有比α_{1 -肾上腺素受体阻滞剂和5α-还原酶强的作用。这种作用允许使用包含Ala-Asp-Glu，Lys-Asp-Glu和Asp-Glu-Gly肽的药物组合物来治疗前列腺增生。} 展开▼

著录项

公开/公告号EA018614B1

专利类型

公开/公告日2013-09-30

原文格式PDF

申请/专利权人 ZAMERTON KHOLDINGS LIMITED;
展开▼

申请/专利号EA20120001417

发明设计人 MIKHAIL VLADIMIROVICH;EVGENIJ ALEKSANDROVICH;PETR ALEKSANDROVICH;
展开▼

申请日2012-11-15

分类号A61K38/04;A61K38/06;A61P13/08;

国家 EA

入库时间 2022-08-21 16:41:48

相似文献

专利

外文文献

中文文献

1. 一种治疗前列腺增生症的药物组合物及其制备方法和用途 [P] . 中国专利： CN109646556A . 2019-04-19

2. 一种治疗良性前列腺增生症的药物组合物及其制备方法和用途 [P] . 中国专利： CN101912448B . 2011.11.09

3. PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE PROSTATE HYPERPLASIA, ITS APPLICATION FOR THE TREATMENT OF THE PROSTATE HYPERPLASIA AND THE METHOD OF TREATING THE PROSTATE HYPERPLASIA [P] . EA201201417A1 . 2013-09-30

机译：用于治疗前列腺增生症的药物组合物，其在前列腺增生症的治疗中的应用以及治疗前列腺增生症的方法

4. roystonea regia pharmaceutical composition for treating and preventing prostate hyperplasia and prostatitis and method of obtaining roystonea regia pharmaceutical composition for treating and preventing prostate hyperplasia and prostatitis [P] . BRPI0409056A . 2006-03-28

机译：用于治疗和预防前列腺增生和前列腺炎的罗伊斯通的药物组合物和获得方法

5. Conjugate, pharmaceutical composition, processes to treat prostate cancer, to treat benign prostatic hyperplasia, and to make a pharmaceutical composition. [P] . BR9712589A . 1999-10-26

机译：结合物，药物组合物，治疗前列腺癌，治疗良性前列腺增生以及制备药物组合物的方法。

1. CLINICAL OBSERVATION ON 60 CASES OF BENIGN HYPERPLASIA OF PROSTATE TREATED BY INJECTION OF "CHUAN-SHEN-TONG" INJECTIO INTO HUIYIN (CV 1) [J] . WANG Runs-heng, GUO Xiao-chuan 世界针灸杂志（英文版） . 2005,第001期

2. A comparative study of thulium laser resection of the prostate-Tangerine technique and transurethral re-section of the prostate for the treatment of benign prostatic hyperplasia [J] . 卓见中国医学文摘：外科学分册英文版 . 2007,第002期

3. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride. [J] . Shibata Y, Fukabori Y, Ito K, The Journal of Urology . 2001,第1期

4. Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: Proceedings from a multidisciplinary research consensus panel [J] . GolzarianJ., AntunesA.A., BilhimT., Journal of vascular and interventional radiology: JVIR . 2014,第5期

5. Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: Proceedings from a multidisciplinary research consensus panel [J] . GolzarianJ., AntunesA.A., BilhimT., Journal of vascular and interventional radiology: JVIR . 2014,第5期

6. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

7. The Feasibility of Fourier Transform Infrared Imaging Spectroscopy in Discriminating Benign Prostatic Hyperplasia From Prostate Cancer in Blood Serum Samples [D] . Monjardez, Geraldine. 2013

8. Factors Affecting the Improvement of the Initial Peak Urinary Flow Rate after Transurethral Resection of the Prostate or Photoselective Vaporization of the Prostate for Treating Benign Prostatic Hyperplasia [O] . Hwa Sub Choi, Dong Jun Kim, Dong Suk Kim, 2011

9. Factors Affecting the Improvement of the Initial Peak Urinary Flow Rate after Transurethral Resection of the Prostate or Photoselective Vaporization of the Prostate for Treating Benign Prostatic Hyperplasia [O] . Choi, Hwa Sub, Kim, Dong Jun, Kim, Dong Suk, 2011

10. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical PracticeGuideline Number 8; Quick Reference Guide for Clinicians Number 8; Treating Your Enlarged Prostate: Patient Guide [R] . 1994

1. An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction, and lower urinary tract symptoms secondary to benign prostatic hyperplasia [J] . Zhe Jin ,Zhi-Chao Zhang ,Ji-Hong Liu . 亚洲男性学杂志：英文版 . 2011,第4期

2. How to Treat Hyperplasia of Prostate Based on TCM Differentiation [J] . 吴沛田 ,段树民（Translated） . 中医杂志：英文版 . 2006,第4期

3. Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients [J] . Gede Wirya Kusuma Duarsa ,Yudit Anastasia Sari ,Anak Agung Gde Oka . 亚洲泌尿外科杂志(英文) . 2021,第3期

4. 良性前列腺增生症中西药物与针灸治疗策略与体会 [C] . 游旭军 ,傅伟 ,李其信 . 中国中医药研究促进会中医生殖医学分会暨男科医学研究院2018年学术年会 . 2018

5. 良性前列腺增生症患者在观察等待、药物治疗和手术治疗三种治疗方案下的临床研究 [A] . 张耀光 . 2006